Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal monitoring-guided treatment for severe aneurysmal subarachnoid hemorrhage
RBR-55t5v9Not yet recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Mar 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam, fentanyl, sodium chloride and thiopental in subarachnoid hemorrhage (SAH) (2 cohorts), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Planned start Mar 2012; status: not yet recruiting.
02
Drugs
midazolamfentanylsodium chloridethiopental
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on RBR-55t5v9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-55t5v9.